Skip to main content
. 2020 Apr 28;12(8):7585–7602. doi: 10.18632/aging.103169

Figure 6.

Figure 6

Kaplan-Meier estimate of 12-year cancer-specific survival (CSS: A) and progression-free survival (PFS: B) of ccRCC patients according to different PTX3 serum levels at baseline.